Breast Cancer clinical trials
Showing 501–550 of 1,067 active trials. Describe your situation to see which ones you may be eligible for.
- Bundled Cancer Screening and Genetic Services Navigation
- Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
- Cardiometabolic Screening Program
- Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
- Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
- [18F] F-GLN by PET/CT in Breast Cancer
- Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge
- Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
- [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
- Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
- Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
- MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
- High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
- Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- FES BPET-DBT in Newly Diagnosed Breast Cancer
- Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
- Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
- PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
- ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
- Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
- Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
- MADRE (Mammograms Available Due to Research and Education)
- Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
- Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
- A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
- A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
- Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- Magnetic Resonance Imaging of Breast Cancer
- Biennial CEM in Women With a Personal History of Breast Cancer
- CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- Evaluation of the Bexa Breast Examination
- Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
- Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
- Mirai-MRI: Validation of AI Models for Breast Cancer Risk
- Breast Cancer PSMA PET
- Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
- Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
- Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
- The Ohio State University (OSU) SCREEN Community Program
- NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
- Imaging of Solid Tumors Using FAP-2286
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Cancer Genetic Testing in Ethnic Populations
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
- F-Tryptophan PET/CT in Human Cancers
- The Cancer of the Pancreas Screening-5 CAPS5)Study
- Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- Intravital Microscopy in Human Solid Tumors
- Identifying and Caring for Individuals With Inherited Cancer Syndrome
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.